FI930263A0 - 3-(1-substituerade pyrazoyl)-2-oxi-indolderivat - Google Patents

3-(1-substituerade pyrazoyl)-2-oxi-indolderivat

Info

Publication number
FI930263A0
FI930263A0 FI930263A FI930263A FI930263A0 FI 930263 A0 FI930263 A0 FI 930263A0 FI 930263 A FI930263 A FI 930263A FI 930263 A FI930263 A FI 930263A FI 930263 A0 FI930263 A0 FI 930263A0
Authority
FI
Finland
Prior art keywords
pyrazoyl
substituted
biosynthesis
interleukin
oxindole derivatives
Prior art date
Application number
FI930263A
Other languages
English (en)
Other versions
FI930263A (fi
FI107609B (fi
Inventor
Carl Joseph Goddard
Gary Richard Schulte
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of FI930263A publication Critical patent/FI930263A/fi
Publication of FI930263A0 publication Critical patent/FI930263A0/fi
Application granted granted Critical
Publication of FI107609B publication Critical patent/FI107609B/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI930263A 1990-07-24 1993-01-22 Menetelmä terapeuttisesti käyttökelpoisten 3-(1-substituoituja pyratsoyyli)-2-oksi-indolijohdannaisten valmistamiseksi FI107609B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US07/557,265 US5064851A (en) 1990-07-24 1990-07-24 3-(1-substituted-pyrazoyl)-2-oxindole derivatives, compositions and use
US55726590 1990-07-24
US9104043 1991-06-12
PCT/US1991/004043 WO1992001684A1 (en) 1990-07-24 1991-06-12 3-(1-substitutedpyrazoyl)-2-oxindole derivatives

Publications (3)

Publication Number Publication Date
FI930263A FI930263A (fi) 1993-01-22
FI930263A0 true FI930263A0 (fi) 1993-01-22
FI107609B FI107609B (fi) 2001-09-14

Family

ID=24224706

Family Applications (1)

Application Number Title Priority Date Filing Date
FI930263A FI107609B (fi) 1990-07-24 1993-01-22 Menetelmä terapeuttisesti käyttökelpoisten 3-(1-substituoituja pyratsoyyli)-2-oksi-indolijohdannaisten valmistamiseksi

Country Status (13)

Country Link
US (1) US5064851A (fi)
EP (1) EP0540614B1 (fi)
JP (1) JP2504659B2 (fi)
AT (1) ATE141601T1 (fi)
CA (1) CA2086432C (fi)
DE (1) DE69121571T2 (fi)
DK (1) DK0540614T3 (fi)
ES (1) ES2090345T3 (fi)
FI (1) FI107609B (fi)
GR (1) GR3021291T3 (fi)
IE (1) IE74689B1 (fi)
PT (1) PT98404B (fi)
WO (1) WO1992001684A1 (fi)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5698399A (en) * 1996-04-05 1997-12-16 Duff; Gordon W. Detecting genetic predisposition for osteoporosis
ID21775A (id) * 1996-10-25 1999-07-22 Yoshitomi Pharmaceutical Senyawa-senyawa 1-fenilpirazol dan penggunaan farmasinya
EP1270565B1 (en) * 1997-01-29 2004-06-30 Pfizer Inc. 4-Substituted furan-2-sulfonamide and its use in the preparation of sulfonyl urea derivatives
PL335052A1 (en) * 1997-01-29 2000-03-27 Pfizer Derivatives of sulphonylurea and their application in regulating activity of interleukin-1
AU3387999A (en) * 1998-04-08 1999-10-25 Abbott Laboratories Pyrazole inhibitors of cytokine production
BR0107704A (pt) * 2000-01-20 2002-11-19 Nortel Networks Ltd Estrutura de quadro para canais sem fio de velocidade variável transmitindo dados de alta velocidade
EP2424521A4 (en) 2009-04-29 2015-03-04 Amarin Pharmaceuticals Ie Ltd PHARMACEUTICAL COMPOSITIONS COMPRISING EPA AND CARDIOVASCULAR AGENT AND METHODS OF USE

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3259622A (en) * 1962-09-07 1966-07-05 Merck & Co Inc 1-benzyl-3-indolyl-alpha-haloalkyl and alkylidenyl acetic acids
DE3310891A1 (de) * 1983-03-25 1984-09-27 Boehringer Mannheim Gmbh, 6800 Mannheim Neue indolinon-(2)-derivate, verfahren zu ihrer herstellung, diese verbindungen enthaltende arzneimittel und zwischenprodukte
US4556672A (en) * 1984-03-19 1985-12-03 Pfizer Inc. 3-Substituted 2-oxindole-1-carboxamides as analgesic and anti-inflammatory agents
US4569942A (en) * 1984-05-04 1986-02-11 Pfizer Inc. N,3-Disubstituted 2-oxindole-1-carboxamides as analgesic and antiinflammatory agents
US4861794A (en) * 1988-04-13 1989-08-29 Pfizer Inc. 3-substituted-2-oxindole-1-carboxamides as inhibitors of interleukin-1 biosynthesis
US5047554A (en) * 1989-04-18 1991-09-10 Pfizer Inc. 3-substituted-2-oxindole derivatives

Also Published As

Publication number Publication date
GR3021291T3 (en) 1997-01-31
DE69121571D1 (de) 1996-09-26
EP0540614B1 (en) 1996-08-21
PT98404B (pt) 1999-01-29
PT98404A (pt) 1992-05-29
DE69121571T2 (de) 1997-01-09
ES2090345T3 (es) 1996-10-16
DK0540614T3 (da) 1996-09-09
ATE141601T1 (de) 1996-09-15
IE912574A1 (en) 1992-01-29
JP2504659B2 (ja) 1996-06-05
US5064851A (en) 1991-11-12
JPH05504773A (ja) 1993-07-22
EP0540614A1 (en) 1993-05-12
CA2086432A1 (en) 1992-01-25
CA2086432C (en) 1997-12-16
FI930263A (fi) 1993-01-22
IE74689B1 (en) 1997-07-30
FI107609B (fi) 2001-09-14
WO1992001684A1 (en) 1992-02-06

Similar Documents

Publication Publication Date Title
BG91773A (bg) Заместени на трето място производни на 2-оксиндола
MXPA03011681A (es) Uso de inhibidores de epoxido hidrolasa soluble, para tratar enfermedades relacionadas con la enfermedad cardiovascular.
EA200000358A1 (ru) Способ получения диарилпиридинов, полезных в качестве ингибиторов cox-2
IL154710A0 (en) Isoxazole derivatives and pharmaceutical compositions containing the same
ES2058292T3 (es) Derivados de indol.
MA27769A1 (fr) Dérivées de 2-acylamino-4-phenylthiazole, leur préparation et leur application en thérapeutique
NO20083411L (no) Indaneddiksyrederivater og deres anvendelse som farmasoytiske midler, intermediater og fremgangsmater for fremstilling
MXPA04000328A (es) Derivados de alfa-hidroxiamida estatina para tratamiento de enfermedad de alzheimer.
EA200870373A1 (ru) Пиридил- и пиримидинилзамещённые производные пиррола, тиофена и фурана в качестве ингибиторов киназ
NO20050016L (no) Difenylazetidinonderivater for behandling av forstyrrelser i lipid metabolismen
NZ312840A (en) Ketoheterocyclic inhibitors of factor Xa
DK391289A (da) Indolderivater
MXPA03011954A (es) Nuevos derivados de acido sulfonico.
WO2003063791A3 (en) Non-steroidal analogs of 2-methoxyestradiol
MXPA02011858A (es) Inhibidores de adhesion de celula mediada por alfabeta2.
FI930263A (fi) 3-(1-substituerade pyrazoyl)-2-oxi-indolderivat
EA200300066A1 (ru) Производные аминоалкоксибензоил-бензофурана или бензотиофена, способ их получения и содержащие их композиции
CY1108187T1 (el) Μεθοδος για την παρασκευη παραγωγων της (3-οξο 2,3-διυδρο-1η-ισοϊνδολ-1-υλο)-ακετυλογουανιδινης
NO994049L (no) Metode for aa fremstille farmasöytiske forbindelser
FR2431508A1 (fr) Sels inorganiques de derives de trimethylammonium de macrolides de polyene, notamment sels inorganiques d'esters methyliques de ces derives et leur procede d'obtention
HK1050141A1 (en) Inhibitor for 20-hete-yielding enzyme
NO904135L (no) Fremgangsmaate for fremstilling av nye substituerte alkylpiperidiner og deres anvendelse som inhibitorer av kolesterolsyntese.
ATE277018T1 (de) 3,4-dihydrochinolin-derivative als stickstoffmonoxid-synthase (nos) inhibitoren
NO20022361L (no) Fremgangsmåte for fremstilling av konjugert linolsyre
MA27070A1 (fr) Nouveaux derives de l'isoquinoleine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Legal Events

Date Code Title Description
MA Patent expired